Skip to main content
Publications
Sauchelli S, Jimenez-Murcia S, Fernandez-Garcia JC, Garrido-Sanchez L, Tinahones FJ, Casanueva FF, Banos RM, Botella C, Crujeiras AB, de la Torre R, Fernandez-Real JM, Fruhbeck G, Granero R, Ortega FJ, Rodriguez A, Zipfel S, Giel KE, Menchon JM, Fernandez-Aranda F. Interaction between orexin-A and sleep quality in females in extreme weight conditions. Eur Eat Disord Rev. 2016 Nov;24(6):510-7. doi: 10.1002/erv.2484
Nastoupil LJ, Sinha R, Byrtek M, Ziemiecki R, Zhou X, Taylor M, Friedberg JW, Link BK, Cerhan JR, Dawson K, Flowers CR. Outcomes following watchful waiting for stage II–IV follicular lymphoma patients in the modern era. Br J Haematol. 2016 Mar;172(5):724-34. doi: 10.1111/bjh.13895
Nabhan C, Byrtek M, Rai A, Dawson K, Zhou X, Link BK, Friedberg JW, Zelenetz AD, Maurer MJ, Cerhan JR, Flowers CR. Disease characteristics, treatment patterns, prognosis, outcomes and lymphoma-related mortality in elderly follicular lymphoma in the United States. Br J Haematol. 2015 Jul;170(1):85-95. doi: 10.1111/bjh.13399
Jimenez-Murcia S, Granero R, Moragas L, Steiger H, Israel M, Aymami N, Gomez-Pena M, Sauchelli S, Aguera Z, Sanchez I, Riesco N, Penelo E, Menchon JM, Fernandez-Aranda F. Differences and similarities between bulimia nervosa, compulsive buying and gambling disorder. Eur Eat Disord Rev. 2015 Mar;23(2):111-8. doi: 10.1002/erv.2340
Granero R, Hilker I, Aguera Z, Jimenez-Murcia S, Sauchelli S, Islam MA, Fagundo AB, Sanchez I, Riesco N, Dieguez C, Soriano J, Salcedo-Sanchez C, Casanueva FF, de la Torre R, Menchon JM, Gearhardt AN, Fernandez-Aranda F. Food addiction in a Spanish sample of eating disorders: DSM-5 diagnostic subtype differentiation and validation data. Eur Eat Disord Rev. 2014 Nov;22(6):389-96. doi: 10.1002/erv.2311
Harrison CN, Mesa RA, Kiladjian J-J, Al-Ali H-K, Gisslinger H, Knoops L, Squier M, Sirulnik A, Mendelson E, Zhou X, Copley-Merriman C, Hunter DS, Levy RS, Cervantes F, Passamonti F, Barbui T, Barosi G, Vannucchi AM. Health-related quality of life and symptoms in patients with myelofibrosis treated with ruxolitinib versus best available therapy. Br J Haematol. 2013 Jul;162(2):229-39. doi: 10.1111/bjh.12375